|  | Conditions & Treatments | Lupus

Eastern Equine Encephalitis (EEE): Mortality, Symptoms, Transmission, and Prevention

Overview

Eastern equine encephalitis virus (EEEV) is a mosquito-borne alphavirus (Togaviridae) causing rare but severe neuroinvasive disease. It is endemic in freshwater hardwood swamps of the Atlantic and Gulf Coast states, the Great Lakes region, the Caribbean, and Central and South America.

Epidemiology

  • Human cases: 5–15 per year in the US (highly variable)
  • Incubation: 4–10 days
  • Most infections are asymptomatic or mild febrile illness; <5% progress to encephalitis.
  • Case-fatality rate (CFR): ~30–35% (highest of any arbovirus in the US)
  • Survivors: >50% have permanent neurologic sequelae (seizures, paralysis, cognitive impairment, behavioral changes).
  • Highest risk: <15 and >50 years; immunocompromised individuals.

Transmission Cycle

  • Enzootic cycle: Culiseta melanura (bird-biting mosquito) ↔ passerine birds (amplifying hosts).
  • Bridge vectors: Coquillettidia perturbans, Aedes spp., Culex spp.—bite birds and mammals (horses, humans).
  • Dead-end hosts: Humans and horses (low viremia) do not amplify the virus.

Clinical Presentation

Systemic Febrile Illness (Mild)

  • Fever, chills, myalgia, malaise, arthralgia—resolves in 1–2 weeks.

Neuroinvasive Disease (EEE)

  • Abrupt onset: high fever, severe headache, vomiting, altered mental status, seizures (common), focal deficits, cranial nerve palsies, coma.
  • CSF: neutrophilic pleocytosis (early) → lymphocytic; elevated protein; normal or low glucose.
  • MRI: bilateral basal ganglia, thalami, brainstem T2/FLAIR hyperintensities (characteristic).

Diagnosis

  • IgM ELISA (CSF/serum)—confirm with PRNT (plaque reduction neutralization test).
  • RT-PCR (CSF) early—low sensitivity.
  • Rule out: HSV, WNV, enteroviruses, autoimmune encephalitis.

Treatment

  • No specific antiviral. Supportive care: ICU, seizure control (benzodiazepines, phenytoin/levetiracetam), ICP management, ventilation, fluids.
  • IVIG, corticosteroids—anecdotal; no RCT evidence.

Prevention

  • No human vaccine. Equine vaccine available (killed virus).
  • Mosquito bite prevention: EPA-registered repellents (DEET, picaridin, IR3535, oil of lemon eucalyptus), permethrin-treated clothing, screens, eliminate standing water.
  • Surveillance: mosquito pools, sentinel chickens, equine cases, human cases → targeted adulticiding.

Public Health Significance

EEEV is a Category B bioterrorism agent (aerosol potential). Climate change may expand vector range. A One Health approach integrates human, veterinary, and environmental surveillance.

Lupus - Related Articles